NewcelX partners with Eledon to develop diabetes treatment
Go back to NewcelX partners with Eledon to develop diabetes treatment| (NASDAQ: ELDN) | Delayed: 3.57 -0.01 (0.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.58 | 52 Week High | $ | |||
| Open | $3.67 | 52 Week Low | $ | |||
| Day High | $3.77 | P/E | N/A | |||
| Day Low | $3.54 | EPS | $ | |||
| Volume | 1,575,111 | |||||
| (NASDAQ: NCEL) | Delayed: 3.60 -0.16 (4.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.76 | 52 Week High | $ | |||
| Open | $3.70 | 52 Week Low | $ | |||
| Day High | $3.77 | P/E | N/A | |||
| Day Low | $3.41 | EPS | $ | |||
| Volume | 7,285 | |||||

